[HTML][HTML] Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron …

M Arabi, Y Al-Najjar, O Sharma, I Kamal, A Javed… - BMC Infectious …, 2023 - Springer
Abstract Background The SARS-CoV-2 virus elicited a major public concern worldwide
since December 2019 due to the high number of infections and deaths caused by COVID …

The incidence of SARS-CoV-2 reinfection in persons with naturally acquired immunity with and without subsequent receipt of a single dose of BNT162b2 vaccine: a …

S Gazit, R Shlezinger, G Perez, R Lotan… - Annals of Internal …, 2022 - acpjournals.org
Background: There is insufficient evidence regarding the magnitude and durability of
protection conferred by a combined effect of naturally acquired immunity after SARS-CoV-2 …

[HTML][HTML] Exercise after influenza or COVID-19 vaccination increases serum antibody without an increase in side effects

J Hallam, T Jones, J Alley, ML Kohut - Brain, behavior, and immunity, 2022 - Elsevier
Vaccination is an effective public health measure, yet vaccine efficacy varies across different
populations. Adjuvants improve vaccine efficacy but often increase reactogenicity. An …

[HTML][HTML] Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA. 1 and BA. 4 6 months after …

SA Madhi, G Kwatra, SI Richardson… - The Lancet Infectious …, 2023 - thelancet.com
Background COVID-19 vaccine rollout is lagging in Africa, where there has been a high rate
of SARS-CoV-2 infection. We aimed to evaluate the effect of SARS-CoV-2 infection before …

[HTML][HTML] Understanding the challenges to COVID-19 vaccines and treatment options, herd immunity and probability of reinfection

MAI Al-Hatamleh, MA Abusalah, MH Ma'mon… - Journal of Taibah …, 2023 - Elsevier
Since it was first reported in Wuhan, China, in December 2019, communicable coronavirus
disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 …

[HTML][HTML] Screening and characterization of shark-derived VNARs against SARS-CoV-2 spike RBD protein

YL Chen, JJ Lin, H Ma, N Zhong, XX Xie… - International Journal of …, 2022 - mdpi.com
The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is the major target for
antibody therapeutics. Shark-derived variable domains of new antigen receptors (VNARs) …

Adverse events following immunization with mRNA and viral vector vaccines in individuals with previous severe acute respiratory syndrome Coronavirus 2 infection …

JA Bettinger, MA Irvine, HP Shulha… - Clinical Infectious …, 2023 - academic.oup.com
Background Adults previously infected with severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) develop short-term immunity and may have increased reactogenicity to …

[HTML][HTML] Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years

C Durier, L Ninove, M Lefebvre, A Radenne… - Scientific Reports, 2022 - nature.com
Immune response induced by COVID-19 vaccine booster against delta and omicron variants
was assessed in 65 adults (65–84 years old) early aftesr a first booster dose. An increase in …

[HTML][HTML] Fever after vaccination against SARS-CoV-2 with mRNA-based vaccine associated with higher antibody levels during 6 months follow-up

A Kanizsai, T Molnar, R Varnai, L Zavori… - Vaccines, 2022 - mdpi.com
Background: The effect of post-vaccination adverse events on immunogenicity is unknown.
We aimed to explore relationship between post-vaccination adverse reactions and antibody …

[HTML][HTML] Comparison of the immune responses to COVID-19 vaccines in Bangladeshi population

P Sarker, E Akhtar, RU Kuddusi, MM Alam, MA Haq… - Vaccines, 2022 - mdpi.com
Background: The adaptive immune response is a crucial component of the protective
immunity against SARS-CoV-2, generated after infection or vaccination. Methods: We …